Result entries:  4630
DRACP ID Peptide Name Sequence Sequence Length Origin
DRACP02861 Ixosin [H3A,E8K,E13L,S16V], Ixosin-pch-H3A GLAKVMRKVLGYLRNVYK 18 Synthetic
DRACP02862 Ixosin (4-18)[E8K,E13L,S16V], Ixosin-pch4–18 KVMRKVLGYLRNVYK 15 Synthetic
DRACP02863 Ixosin (1-12) GLHKVMREVLGY 12 Synthetic
DRACP02864 Ixosin (12-23) YERNSYKKFFLR 12 Synthetic
DRACP02865 Ixosin (1-18) GLHKVMREVLGYERNSYK 18 Synthetic
DRACP02866 Ixosin (4-18) KVMREVLGYERNSYK 15 Synthetic
DRACP02867 Ixosin (7-18) REVLGYERNSYK 12 Synthetic
DRACP02868 LL-37 (17-29) [F17L] LKRIVQRIKDFLR 13 Synthetic
DRACP02869 LL-37 (17-29) [F17A] AKRIVQRIKDFLR 13 Synthetic
DRACP02870 LL-37 (17-29) [K25L] FKRIVQRILDFLR 13 Synthetic
DRACP02871 LL-37 (17-29) [18SA-K] [K25L] FXRIVQRILDFLR 13 Synthetic
DRACP02872 LL-37 (17-29) [K25R] FKRIVQRIRDFLR 13 Synthetic
DRACP02873 LL-37 (17-29) [K25R]-Ac FKRIVQRIRDFLR 13 Synthetic
DRACP02874 LL-37 (17-29) [R23K] FKRIVQKIKDFLR 13 Synthetic
DRACP02875 LL-37 (17-29) [R23L] FKRIVQLIKDFLR 13 Synthetic
DRACP02876 LL-37 (17-29) [R23L]-Ac FKRIVQLIKDFLR 13 Synthetic
DRACP02877 LL-37 (17-29) [F27L] FKRIVQRIKDLLR 13 Synthetic
DRACP02878 LL-37 (17-29) [F27L]-Ac FKRIVQRIKDLLR 13 Synthetic
DRACP02879 LL-37 (17-29) [R23I,D26K] FKRIVQIIKKFLR 13 Synthetic
DRACP02880 LL-37 (17-29) [R23I,D26K]-Ac FKRIVQIIKKFLR 13 Synthetic
DRACP02881 LL-37 (17-29) [R23L,I24L,D26K,F27L] FKRIVQLLKKLLR 13 Synthetic
DRACP02882 LL-37 (17-29) [R23L,I24L,D26K,F27L]-Ac FKRIVQLLKKLLR 13 Synthetic
DRACP02883 LL-37 (17-29) [V21L] FKRILQRIKDFLR 13 Synthetic
DRACP02884 LL-37 (17-29) [V21L]-Ac FKRILQRIKDFLR 13 Synthetic
DRACP02885 CEN1 HC-Br GXFKKTFHKVSHAVKSGIHAGQRGCSALGF 30 Synthetic
DRACP02886 CEN1 HC GWFKKTFHKVSHAVKSGIHAGQRGCSALGF 30 Synthetic
DRACP02887 CEN1 HC (1–20) GWFKKTFHKVSHAVKSGIHA 20 Synthetic
DRACP02888 CEN1 HC (Ser) GWFKKTFHKVSHAVKSGIHAGQRGSSALGF 30 Synthetic
DRACP02889 H-2, Hymenochirin-1B [E6,N10 S5] IKLSPⓍTKDⓍLKKVLKGAIKGAIAVAKMV 29 Synthetic (Derived from Hymenochirin-1B)
DRACP02890 H-5, Hymenochirin-1B [A18,A22 S5] IKLSPETKDNLKKVLKGⓍIKGⓍIAVAKMV 29 Synthetic (Derived from Hymenochirin-1B)
<< < 93 94 95 96 97 >>

DRACP is developed by Dr.Zheng's team.